News Oligomerix to Present at AAIC 2020 Conference on Small Molecule Inhibitor of Tau Self-Association July 23, 2020 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix Receives $3.19 Million NIH Commercialization Readiness Pilot Grant for Alzheimer’s Disease TherapyNext →Oligomerix Appoints William Erhardt, M.D., as Chief Medical Officer
